GoodRx Holdings, Inc.

GDRX Healthcare Health Information Services

GoodRx Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $796.9 million, up 0.57% from fiscal 2024. In the quarter to June 2026, revenue fell 1.31%, EPS fell 25.0%, free cash flow grew 112.5% and total debt was flat, each against the same quarter a year earlier.

3.36 0.15 −4.27%
Market cap
$1.2B
P/E
62.7×
Fwd P/E
30.9×
Dividend yield
—
F-score
6/9
Altman Z
0.44
Beneish M
−2.40
Dividend safety
n/a

A Cash Flow Statement is a financial report that details the cash inflows and outflows of a company over a specific period. It is divided into three sections: operating activities, investing activities, and financing activities. This statement helps assess the company’s liquidity, solvency, and overall financial health. By tracking cash movements, it provides insights into the company's ability to generate cash to fund operations, pay debts, and invest in growth. Businesses and investors use it to evaluate the sustainability of a company's cash flow and its financial stability.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Net Income
30.44 16.39 (8.87) (32.83) (25.25) (293.62) 66.05 43.79 0.00 (7.77)
Depreciation & Amortization
86.99 72.04 111.05 57.59 37.98 21.82 16.95 11.05 — —
Non Cash Items (Other)
102.51 93.37 56.69 129.74 176.42 435.60 5.10 2.19 — —
Accounts Receivable Change
(88.02) (2.33) (26.47) 1.38 (43.95) (16.14) (14.52) (12.84) — —
Accounts Payable Change
4.10 (15.82) 12.03 (0.87) 4.21 2.15 0.52 0.67 — —
Change in payables and accrued liability
1.19 9.91 21.25 (5.27) 14.00 15.01 11.23 0.08 — —
Change in other assets and liabilities
30.69 10.33 (27.40) (2.95) 15.38 (33.48) (2.04) 0.33 — —
Other operating activities
— — — — — — — — 0.00 —
Operating Cash Flow
167.90 183.89 138.29 146.78 178.78 131.34 83.29 45.25 — —
Capital expenditures
(74.02) (70.35) (55.77) (55.21) (34.46) (35.82) (5.75) (3.46) — —
Net Aquisitions
(43.44) — — (140.28) (140.27) (55.79) (31.31) — — —
Short Term Investments Change (Net)
— — — (15.01) (4.01) — — — — —
Other investing activities
(2.50) — — (20.63) (58.52) (78.71) — — — —
Investing cash flow
(119.96) (70.35) (55.77) (210.50) (178.73) (91.62) (37.05) (3.46) — —
Repayment/Issuance of Debt (Net)
(5.00) (167.00) (5.27) (7.03) (7.03) (7.03) (57.23) 606.88 — —
Equity Repurchase (Common, Net)
(215.00) (138.03) (96.64) (92.56) 35.02 992.87 4.67 3.35 — —
Equity Repurchase (Preffered, Net)
— — — — — — — 737.01 — —
Dividends Paid (Total)
— — — — — — — (1,346.35) — —
Other financial activities
(14.47) (32.46) (65.48) (20.63) (58.52) (80.02) (2.21) (25.61) — —
Financing cash flow
(234.47) (337.49) (167.39) (120.23) (30.53) 905.82 (54.78) (24.73) — —
Change in Cash
(186.53) (223.95) (84.87) (183.94) (30.48) 945.54 (8.55) 17.06 — —
Beginning Cash
448.35 672.30 757.17 941.11 971.59 26.05 34.60 17.54 — —
Ending Cash
261.82 448.35 672.30 757.17 941.11 971.59 26.05 34.60 — —
Stock Based Compensation
76.63 99.03 104.82 120.23 160.46 397.29 3.75 1.76 — —
Dividends Paid (Common)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 (1,346.35) 0.00 —
Net Cash/Marketcap
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Assets Liabilities Change (Total)
(52.03) 2.09 (20.58) (7.72) (10.37) (32.46) (4.82) (11.77) — —
Investments Change (Net)
— — — (15.01) (4.01) — — — — —
Issuance/Purchase of Shares
(215.00) (138.03) (96.64) (92.56) 35.02 992.87 4.67 740.36 — —
Other line items
Revenue per Employee
1.14 1.07 1.08 0.80 0.96 1.15 1.15 0.00 0.00 0.00

Fold the line items

In millions of $ except per-share values · columns are period end dates